159 related articles for article (PubMed ID: 7553681)
21. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
22. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
23. [Study of c-erbB-2 expression in breast neoplasms].
Ye F
Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):104-6. PubMed ID: 8104720
[TBL] [Abstract][Full Text] [Related]
24. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.
González-Vela MC; Garijo MF; Fernández F; Val-Bernal JF
Histol Histopathol; 2001 Apr; 16(2):399-406. PubMed ID: 11332695
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
[TBL] [Abstract][Full Text] [Related]
26. Biologic characteristics of breast cancer detected by mammography and by palpation in a screening program: a pilot study.
Tweedie E; Tonkin K; Kerkvliet N; Doig GS; Sparrow RK; O'Malley FP
Clin Invest Med; 1997 Oct; 20(5):300-7. PubMed ID: 9336655
[TBL] [Abstract][Full Text] [Related]
27. Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma.
Spiethoff A; Schenck A; Bohrer M
J Cancer Res Clin Oncol; 2000 Dec; 126(12):707-10. PubMed ID: 11153143
[TBL] [Abstract][Full Text] [Related]
28. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
29. Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma.
Silver SA; Tavassoli FA
Histopathology; 2000 Jun; 36(6):505-14. PubMed ID: 10849092
[TBL] [Abstract][Full Text] [Related]
30. [Transplantation of human primary in-situ and invasive breast carcinoma in nude mice].
He L; Andersen JA
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):321-3. PubMed ID: 9387265
[TBL] [Abstract][Full Text] [Related]
31. Karyotypic heterogeneity and its relation to labeling index in interphase breast tumor cells.
Balazs M; Matsumura K; Moore D; Pinkel D; Gray JW; Waldman FM
Cytometry; 1995 May; 20(1):62-73. PubMed ID: 7600900
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of EZH2, paxillin expression and DNA ploidy of breast adenocarcinoma: correlation to pathologic predictors.
Panousis D; Xepapadakis G; Lagoudianakis E; Karavitis G; Salemis N; Koronakis N; Patsouris E; Koronarchis D; Grosomanidis D; Chryssikos G; Ntasiou P; Kyriakidou V; Athanassiadou AM; Athanassiadou P
J BUON; 2013; 18(4):879-85. PubMed ID: 24344012
[TBL] [Abstract][Full Text] [Related]
33. DNA ploidy analyses in 218 consecutive Pakistani breast cancer patients: does it add anything?
Khan E; Mapara Z; Khan S; Arshad N; Siddiqui T; Pervez S
Pathol Oncol Res; 2001; 7(2):125-8. PubMed ID: 11458275
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
35. Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer.
Pinto AE; André S; Laranjeira C; Soares J
Pathology; 2005 Feb; 37(1):45-50. PubMed ID: 15875733
[TBL] [Abstract][Full Text] [Related]
36. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
37. A flow cytometric study of c-erbB-3 expression in breast cancer.
Brotherick I; Shenton BK; Angus B; Waite IS; Horne CH; Lennard TW
Cancer Immunol Immunother; 1995 Nov; 41(5):280-6. PubMed ID: 8536273
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections.
Siitonen SM; Kallioniemi OP; Helin HJ; Isola JJ
Hum Pathol; 1993 Dec; 24(12):1348-53. PubMed ID: 8276382
[TBL] [Abstract][Full Text] [Related]
39. Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters.
García Muñiz JL; Alvarez A; Fernández Llana B; Fernández Raigoso P; Allende MT; Ruibal A
Int J Biol Markers; 1995; 10(2):119-21. PubMed ID: 7561238
[No Abstract] [Full Text] [Related]
40. Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy.
Ottesen GL; Christensen IJ; Larsen JK; Larsen J; Baldetorp B; Linden T; Hansen B; Andersen J
Breast Cancer Res Treat; 2000 Apr; 60(3):219-26. PubMed ID: 10930109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
